YolTech Therapeutics
PrivateLast Round
Series C
May 28, 2026
Total Funding Raised
$147M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
YolTech Therapeutics is a biotechnology company that develops in vivo gene-editing therapies for serious genetic, metabolic, and cardiovascular diseases using proprietary CRISPR-Cas and lipid nanoparticle delivery platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
YolTech Therapeutics Comparables
Compare YolTech Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Arbor Biotechnologies | 83% | |
| CorrectSequence Therapeutics | 82% | |
| Base Therapeutics | 82% | |
YolTech Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 28, 2026 | ||||
| Series B | Sep 11, 2025 | ||||
| Series A Extension | Nov 1, 2023 | ||||
| Series A | Aug 1, 2022 |
YolTech Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Loyal Valley Capital | Series C |
| Unity Ventures | Series A |
| 险峰K2VC | Series C, Series A |
| 松禾资本 (Green Pine Capital Partners) | Series B |
| Decheng Capital | Series B, Series A Extension |
| Grand Flight Investment | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2025
$45M round led by AstraZeneca-CICC Healthcare Industrial Fund.
YolTech Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about YolTech Therapeutics's valuation, stock price, and market status.